NCT01559168View on ClinicalTrials.gov

Uphold Mesh for the Surgical Treatment of Uterine-predominant Prolapse

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

July 15, 2016

Study Completion Date

July 15, 2016

Conditions
Pelvic Organ Prolapse
Interventions
DEVICE

UpholdTM LITE placement

Uphold TM LITE mesh is used for the surgical correction of pelvic organ prolapse.

Trial Locations (13)

13385

APHM - Hôpital de la Conception, Marseille

30029

CHU de Nîmes - Hôpital Universitaire Carémeau, Nîmes

34070

Clinique Beau Soleil, Montpellier

34295

CHU de Montpellier - Hôpital Lapeyronie, Montpellier

59037

CHRU de Lille - Hôpital Jeanne de Flandre, Lille

59385

CH de Dunkerque, Dunkirk

63003

CHU de Clermont Ferrand - Hôpital Estaing, Clermont-Ferrand

69317

CHRU de Lyon - Hôpital de la Croix Rousse, Lyon

84106

CH Louis Giorgi, Orange

86021

CHU de Poitiers, Poitiers

86106

CH Camille Guérin, Châtellerault

92150

Hôpital Foch, Suresnes

95500

CH de Gonesse, Gonesse

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT01559168 - Uphold Mesh for the Surgical Treatment of Uterine-predominant Prolapse | Biotech Hunter | Biotech Hunter